US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

RCN Pareto Strategic Allocation ETF

27.20

+0.06900.25%

Volume:208

Turnover:5.66K

Market Cap:17.06M

PE:- -

High:27.20

Open:27.20

Low:27.20

Close:27.13

52wk High:28.58

52wk Low:24.68

Shares:627.19K

Float Shares:627.19K

Volume Ratio:0.67

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Aixtron price target lowered to EUR 54 from EUR 60 at JPMorgan

AxoGen price target lowered to $53 from $60 at Truist

60 Degrees Pharmaceuticals Announces Date for Hospitalized Babesiosis Study Interim Data Release and Key Opinion Leader Webinar

Inspire Medical price target raised to $75 from $60 at RBC Capital

Agomab Posts Positive 60-Week Data for Ontunisertib in Fibrostenosing Crohn’s Disease, Readies Phase 2b NOV-ERA Trial

Truist Cuts Price Target on Axogen to $53 From $60, Keeps Buy Rating

MT Newswires Live

RBC Raises Price Target on Inspire Medical Systems to $75 From $60, Keeps Sector Perform Rating

MT Newswires Live

Goosehead Insurance price target lowered to $60 from $68 at JPMorgan

Analyst Maintains Buy on Alaska Air, Reaffirming Unchanged $60 Price Target Amid Strategic Margin Upside

TriIs Finalizes JPY 600 Million Acquisition of LIMNO as Wholly Owned Subsidiary

Glory Advances Share Buyback, Repurchasing 1.38 Million Shares Under Current Mandate

IPD Group Cancels 60,079 Performance Rights Under Agreed Cessation

Cangzhou's 60-plus lion dance troupes busy with National Day performances — 'averaging more than ten shows a day'

Here's the Most You Should be Spending on Your Car Payment, Whether You Make $60,000 or over $150,000

AnaptysBio price target lowered to $60 from $70 at JPMorgan

Nanning Highway Set to Open, Ending Over 60 Years of Ferry Reliance

Truist Raises Price Target on CarMax to $60 From $50, Keeps Hold Rating

MT Newswires Live

Celanese price target lowered to $58 from $60 at Citi

GUSHENGTANG Cancels 600,000 Repurchased Shares on September 30

Citigroup Downgrades Moderna to Sell From Neutral, Adjusts Price Target to $80 From $60

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/PRTO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRTO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRTO\",,,,,undefined,":{"symbol":"PRTO","market":"US","secType":"STK","nameCN":"RCN Pareto Strategic Allocation ETF","latestPrice":27.2,"timestamp":1790884155665,"preClose":27.131,"halted":0,"volume":208,"delay":0,"changeRate":0.0025432162470973817,"floatShares":627188,"shares":627188,"eps":0,"marketStatus":"Trading","change":0.069,"latestTime":"10-01 15:58:40 EDT","open":27.2,"high":27.2,"low":27.2,"amount":5656.460784,"amplitude":0,"askPrice":27.86,"askSize":100,"bidPrice":26.69,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790884800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1413950400000,"exchange":"ARCA","adjPreClose":27.131,"nav":27.18,"aum":17046969.84,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":27.15,"preClose":27.131,"latestTime":"16:04 EDT","volume":4,"amount":108.524,"timestamp":1790798644882,"change":0.019,"changeRate":0.0007,"amplitude":0},"volumeRatio":0.672692},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRTO\",,,,,undefined,":{"symbol":"PRTO","floatShares":627188,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.672692,"shares":627188,"dividePrice":0,"high":27.2,"amplitude":0,"preClose":27.131,"low":27.2,"week52Low":24.6845,"pbRate":"--","week52High":28.5818,"institutionHeld":0,"latestPrice":27.2,"eps":0,"divideRate":0,"volume":208,"delay":0,"ttmEps":0,"open":27.2,"prevYearClose":25.39,"prevWeekClose":27.575,"prevMonthClose":27.131,"prevQuarterClose":27.131,"fiveDayClose":27.5139,"twentyDayClose":27.9481,"sixtyDayClose":27.3358},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRTO\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRTO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRTO\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PRTO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672761342","title":"Aixtron price target lowered to EUR 54 from EUR 60 at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2672761342","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672761342?lang=en_us&edition=fundamental","pubTime":"2026-10-02 02:20","pubTimestamp":1790878837,"startTime":"0","endTime":"0","summary":"JPMorgan analyst Craig McDowell lowered the firm’s price target on Aixtron (AIXXF) to EUR 54 from EUR 60 and keeps an Overweight rating on the shar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aixtron-price-target-lowered-to-eur-54-from-eur-60-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aixtron-price-target-lowered-to-eur-54-from-eur-60-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PGF","PRTO","EUFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672752051","title":"AxoGen price target lowered to $53 from $60 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2672752051","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672752051?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:35","pubTimestamp":1790858139,"startTime":"0","endTime":"0","summary":"Truist analyst Ravi Misra lowered the firm’s price target on AxoGen (AXGN) to $53 from $60 and keeps a Buy rating on the shares. The firm is adjust...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/axogen-price-target-lowered-to-53-from-60-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/axogen-price-target-lowered-to-53-from-60-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AXGN","PRTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672575474","title":"60 Degrees Pharmaceuticals Announces Date for Hospitalized Babesiosis Study Interim Data Release and Key Opinion Leader Webinar","url":"https://stock-news.laohu8.com/highlight/detail?id=2672575474","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672575474?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:03","pubTimestamp":1790856180,"startTime":"0","endTime":"0","summary":"Interim analysis results from clinical study evaluating tafenoquine in severe babesiosis (NCT06207370) to be disclosed on October 6, 2026.Key Opinion Leader investor webinar scheduled for October 6, 2","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/01/3372857/0/en/60-degrees-pharmaceuticals-announces-date-for-hospitalized-babesiosis-study-interim-data-release-and-key-opinion-leader-webinar.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007","PRTO","KOL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672754121","title":"Inspire Medical price target raised to $75 from $60 at RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2672754121","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672754121?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:50","pubTimestamp":1790855444,"startTime":"0","endTime":"0","summary":"RBC Capital raised the firm’s price target on Inspire Medical (INSP) to $75 from $60 and keeps a Sector Perform rating on the shares as part of a b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inspire-medical-price-target-raised-to-75-from-60-at-rbc-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inspire-medical-price-target-raised-to-75-from-60-at-rbc-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672759748","title":"Agomab Posts Positive 60-Week Data for Ontunisertib in Fibrostenosing Crohn’s Disease, Readies Phase 2b NOV-ERA Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2672759748","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672759748?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:57","pubTimestamp":1790852275,"startTime":"0","endTime":"0","summary":"AgomAb Therapeutics NV ADR ( ($AGMB) ) just unveiled an update. On October 1, 2026, Agomab reported positive topline data from the 48-week open-lab...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/agomab-posts-positive-60-week-data-for-ontunisertib-in-fibrostenosing-crohns-disease-readies-phase-2b-nov-era-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/agomab-posts-positive-60-week-data-for-ontunisertib-in-fibrostenosing-crohns-disease-readies-phase-2b-nov-era-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AADR","CVY","SAPH","ARMH","DIVL","DINT","PRTO","APIE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672594537","title":"Truist Cuts Price Target on Axogen to $53 From $60, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2672594537","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672594537?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:51","pubTimestamp":1790851900,"startTime":"0","endTime":"0","summary":"Axogen (AXGN) has an average rating of buy and mean price target of $53.70, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and re","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672759369","title":"RBC Raises Price Target on Inspire Medical Systems to $75 From $60, Keeps Sector Perform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2672759369","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672759369?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:36","pubTimestamp":1790851019,"startTime":"0","endTime":"0","summary":"Inspire Medical Systems (INSP) has an average rating of hold and mean price target of $63.80, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRTO","INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672428755","title":"Goosehead Insurance price target lowered to $60 from $68 at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2672428755","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672428755?lang=en_us&edition=fundamental","pubTime":"2026-10-01 17:35","pubTimestamp":1790847308,"startTime":"0","endTime":"0","summary":"JPMorgan analyst Pablo Singzon lowered the firm’s price target on Goosehead Insurance (GSHD) to $60 from $68 and keeps a Neutral rating on the shar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/goosehead-insurance-price-target-lowered-to-60-from-68-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/goosehead-insurance-price-target-lowered-to-60-from-68-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSHD","PRTO","PGF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672553117","title":"Analyst Maintains Buy on Alaska Air, Reaffirming Unchanged $60 Price Target Amid Strategic Margin Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2672553117","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672553117?lang=en_us&edition=fundamental","pubTime":"2026-10-01 17:06","pubTimestamp":1790845578,"startTime":"0","endTime":"0","summary":"Analyst Andrew Didora from Bank of America Securities maintained a Buy rating on Alaska Air and keeping the price target at $60.00. Andrew Didora h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-alaska-air-reaffirming-unchanged-60-price-target-amid-strategic-margin-upside-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-alaska-air-reaffirming-unchanged-60-price-target-amid-strategic-margin-upside-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRTO","ALK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672535207","title":"TriIs Finalizes JPY 600 Million Acquisition of LIMNO as Wholly Owned Subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2672535207","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672535207?lang=en_us&edition=fundamental","pubTime":"2026-10-01 16:23","pubTimestamp":1790843034,"startTime":"0","endTime":"0","summary":"TriIs Inc. ( ($JP:4840) ) has issued an update. TriIs Inc. has completed the acquisition of all 120,000 issued shares of LIMNO Co., Ltd. for JPY 60...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/triis-finalizes-jpy-600-million-acquisition-of-limno-as-wholly-owned-subsidiary?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/triis-finalizes-jpy-600-million-acquisition-of-limno-as-wholly-owned-subsidiary?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672731204","title":"Glory Advances Share Buyback, Repurchasing 1.38 Million Shares Under Current Mandate","url":"https://stock-news.laohu8.com/highlight/detail?id=2672731204","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672731204?lang=en_us&edition=fundamental","pubTime":"2026-10-01 12:22","pubTimestamp":1790828537,"startTime":"0","endTime":"0","summary":"The latest update is out from Glory ( ($JP:6457) ). Glory Ltd. has reported further progress on its ongoing share buyback program, acquiring 175,60...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/glory-advances-share-buyback-repurchasing-1-38-million-shares-under-current-mandate?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/glory-advances-share-buyback-repurchasing-1-38-million-shares-under-current-mandate?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRTO","ACKY","BRKW","BRKU","BRKL","ACTV","BRKD","BRKC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672573322","title":"IPD Group Cancels 60,079 Performance Rights Under Agreed Cessation","url":"https://stock-news.laohu8.com/highlight/detail?id=2672573322","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672573322?lang=en_us&edition=fundamental","pubTime":"2026-10-01 08:10","pubTimestamp":1790813426,"startTime":"0","endTime":"0","summary":"An update from IPD Group Ltd ( ($AU:IPG) ) is now available. IPD Group Ltd has reported the cessation of 60,079 performance rights, identified unde...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ipd-group-cancels-60079-performance-rights-under-agreed-cessation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ipd-group-cancels-60079-performance-rights-under-agreed-cessation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142805327","title":"Cangzhou's 60-plus lion dance troupes busy with National Day performances — 'averaging more than ten shows a day'","url":"https://stock-news.laohu8.com/highlight/detail?id=1142805327","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142805327?lang=en_us&edition=fundamental","pubTime":"2026-09-30 21:31","pubTimestamp":1790775071,"startTime":"0","endTime":"0","summary":"The Shenyun Dragon and Lion Art Troupe of Cangxian County was performing. \"Look, these young men coordinate so seamlessly — they've practically brought this lion to life!\" \"No wonder it's a...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671202456","title":"Here's the Most You Should be Spending on Your Car Payment, Whether You Make $60,000 or over $150,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2671202456","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671202456?lang=en_us&edition=fundamental","pubTime":"2026-09-30 21:00","pubTimestamp":1790773200,"startTime":"0","endTime":"0","summary":"For car buyers today, saving over a few years for a large down payment can be critical to reducing the amount they borrow and the length of their loanIn this high-cost environment, the most impactful ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671209959","title":"AnaptysBio price target lowered to $60 from $70 at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2671209959","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671209959?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:30","pubTimestamp":1790767812,"startTime":"0","endTime":"0","summary":"JPMorgan lowered the firm’s price target on AnaptysBio (ANAB) to $60 from $70 and keeps an Overweight rating on the shares. The firm updated the co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/anaptysbio-price-target-lowered-to-60-from-70-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/anaptysbio-price-target-lowered-to-60-from-70-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FFTY","PGF","PRTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158132974","title":"Nanning Highway Set to Open, Ending Over 60 Years of Ferry Reliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1158132974","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158132974?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:40","pubTimestamp":1790764854,"startTime":"0","endTime":"0","summary":"On September 29, it was learned from the Nanning Municipal Transport Bureau that the S514 Nanning Jiangxi to Tanluo Highway has successfully passed the completion acceptance inspection and will...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671220316","title":"Truist Raises Price Target on CarMax to $60 From $50, Keeps Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2671220316","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671220316?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:24","pubTimestamp":1790763846,"startTime":"0","endTime":"0","summary":"CarMax (KMX) has an average rating of hold and mean price target of $59.73, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and re","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KMX","PRTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671036372","title":"Celanese price target lowered to $58 from $60 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2671036372","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671036372?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:06","pubTimestamp":1790762774,"startTime":"0","endTime":"0","summary":"Citi lowered the firm’s price target on Celanese (CE) to $58 from $60 and keeps a Buy rating on the shares. The firm no longer has conviction on up...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/celanese-price-target-lowered-to-58-from-60-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/celanese-price-target-lowered-to-58-from-60-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180211733","title":"GUSHENGTANG Cancels 600,000 Repurchased Shares on September 30","url":"https://stock-news.laohu8.com/highlight/detail?id=1180211733","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180211733?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:58","pubTimestamp":1790762289,"startTime":"0","endTime":"0","summary":"GUSHENGTANG (02273) has announced that it cancelled a total of 600,000 repurchased shares on September 30, 2026.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRTO","BK1219","02273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671270627","title":"Citigroup Downgrades Moderna to Sell From Neutral, Adjusts Price Target to $80 From $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2671270627","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671270627?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:36","pubTimestamp":1790761011,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) has an average rating of hold and mean price target of $115.47, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRTO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}